Global Emphysema Treatment Market Projected to Grow at 8% CAGR, Reaching $7.4 Billion by 2029

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Emphysema Treatment Industry Market Size Be by 2025?
The market size for treating emphysema has seen robust growth in the past few years. The expansion is projected to continue, increasing from $5.15 billion in 2024 to $5.43 billion in 2025, measured at a compound annual growth rate (CAGR) of 5.6%. Factors contributing to this growth during the historic period include the repercussions of the smoking epidemic, advances in medication, the introduction of pulmonary rehabilitation programs, enhancements in diagnostic tools, as well as increased awareness and education.

What's the Long-Term Growth Forecast for the Emphysema Treatment Market Size Through 2029?
In the coming years, the market size for emphysema treatment is predicted to witness substantial growth, reaching $7.4 billion by 2029 with an 8.0% compound annual growth rate (CAGR). Factors contributing to this growth during the forecast period include a rising aging population, personalized treatment methods, wider therapy options, emphasis on symptom control, and collaborative healthcare approaches. Key trends for the forecast period comprise gene therapies research, initiatives for patient knowledge and empowerment, incorporation of artificial intelligence (AI), improved treatment accessibility, and the creation of extended-release medications.

View the full report here:
https://www.thebusinessresearchcompany.com/report/emphysema-treatment-global-market-report

What Are the Key Growth Drivers Fueling the Emphysema Treatment Market Expansion?
An increase in the incidence of chronic obstructive pulmonary disease (COPD) is anticipated to spur the expansion of the emphysema treatment market. COPD is a collection of disorders that hinder airflow and create respiratory problems, encompassing chronic bronchitis and emphysema. Emphysema treatment strategies are critical to mitigating the progression of COPD as they concentrate on alleviating symptoms, restoring pulmonary function, and slowing the advancement of the disease. For instance, reports from the Australian Institute of Health and Welfare (AIHW) in June 2024 indicated that approximately 638,000 individuals, or 2.5% of Australia's population, suffered from COPD in 2022. By 2023, this disease accounted for 3.6% of the total disease burden, making up 50% of all respiratory-related conditions. Further, in 2022, COPD was the root cause of 7,691 deaths, equivalent to 29.6 deaths per 100,000 individuals and representing 4.0% of all the country's mortalities. Consequently, the increase in COPD cases boosts the growth of the emphysema treatment market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10807&type=smp

What Are the Key Trends Driving Emphysema Treatment Market Growth?
Leading corporations in the emphysema market are advancing minimally invasive solutions for patients with emphysema in order to maintain their competitive status in the industry. These increasingly popular procedures are characterized by their less disruptive impact on the body's normal physical composition. An example of this came into the market in January 2022 when the American healthcare organization, Adena Health System, introduced the Zephyr Valve operation, a groundbreaking minimally invasive alternative to the more traditional lung volume reduction surgery for those suffering from lung hyperinflation typically seen in emphysema and COPD patients. The modern technique involves implanting tiny, one-way Zephyr Valves into the lung's airways using a bronchoscope. Consequently, these valves aid in the expulsion of trapped air, forestall additional buildup, and enable expansion in the healthier parts of the lung, which enhances respiratory function.

How Is the Emphysema Treatment Market Segmented?
The emphysema treatment market covered in this report is segmented -

1) By Treatment: Smoking Cessation, Bronchodilators, Steroids, Leukotriene Modifiers, Supplemental Oxygen, Antibiotics, Gene Therapy, Surgery Transplant, Other Treatments
2) By Distribution Channel: Online Providers, Drug Stores and Retail Pharmacies, Hospital Pharmacies
3) By End-User: Clinics, Surgical Centre, Other End-Users

Subsegments:
1) By Smoking Cessation: Nicotine Replacement Therapy (NRT), Prescription Medications, Behavioral Therapy Programs
2) By Bronchodilators: Short-Acting Beta-Agonists (SABAs), Long-Acting Beta-Agonists (LABAs), Anticholinergics
3) By Steroids: Inhaled Corticosteroids (ICS), Oral Corticosteroids, Combination Inhalers
4) By Leukotriene Modifiers: Montelukast, Zafirlukast
5) By Supplemental Oxygen: Portable Oxygen Concentrators, Continuous Flow Oxygen Systems, Pulse Dose Oxygen Systems
6) By Antibiotics: Macrolides, Fluoroquinolones, Tetracyclines
7) By Gene Therapy: Gene Replacement Therapy, Antisense Oligonucleotides
8) By Surgery Transplant: Lung Volume Reduction Surgery (LVRS), Lung Transplantation
9) By Other Treatments: Pulmonary Rehabilitation Programs, Nutritional Support, Palliative Care

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=10807&type=smp

Which Companies Are Leading the Charge in Emphysema Treatment Market Innovation?
Major companies operating in the emphysema treatment market include AstraZeneca PLC, Teva Pharmaceutical Industries Ltd., Novartis AG, GlaxoSmithKline PLC, Hikma Pharmaceuticals PLC, Boehringer Ingelheim GmbH, Mylan N.V., Pfizer Inc., Orion Oyj, Verona Pharma PLC, Pulmonx Corporation, Emphasys Medical Inc., Halozyme Therapeutics Inc., Mariposa Health Limited, Uptake Technologies Inc., Respinova Ltd, Gala Therapeutics Inc., Pulmatrix Inc., Broncus Medical Inc., Holaira Inc., PneumRx Inc., Spiration Inc., Aeris Therapeutics Inc., CSA Medical Inc., Olympus Corporation

Which Regions Are Leading the Global Emphysema Treatment Market in Revenue?
North America was the largest region in the emphysema treatment market in 2024. The regions covered in the emphysema treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10807

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.